Dr Ross SOO
Lung cancer is a leading cause of cancer mortality worldwide. Despite the decline of smoking-related lung cancers, the incidence of lung cancer remains high. Epidemiology data now shows an emerging trend of increasing incidence of pulmonary adenocarcinomas – a disease seen predominantly in non-smokers and women. This group of patients has recently been recognized to have a different disease course compared to male smokers with lung cancers, and will account for an increasing proportion of all lung cancer patients in the future. The Lung Cancer Group’s research interests include the evaluation of hormonal factors in the development of lung cancers in non-smoking women, investigating the role of transcription factors in lung cancer, and improving the efficacy of targeted therapy in patients with EGFR mutations.